481 related articles for article (PubMed ID: 16549394)
1. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
[TBL] [Abstract][Full Text] [Related]
2. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
Hokkanen S; Kosunen TU; Sarna S; Miettinen A; Salomaa A; Aromaa A; Knekt P; Rautelin HI
Scand J Clin Lab Invest; 2005; 65(4):291-9. PubMed ID: 16076684
[TBL] [Abstract][Full Text] [Related]
3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
5. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
8. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Wagner S; Chayama K
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):123-7. PubMed ID: 11981335
[TBL] [Abstract][Full Text] [Related]
9. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
11. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany.
Zhang Y; Weck MN; Schöttker B; Rothenbacher D; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):821-6. PubMed ID: 23456556
[TBL] [Abstract][Full Text] [Related]
12. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia.
Egi Y; Ito M; Tanaka S; Imagawa S; Takata S; Yoshihara M; Haruma K; Chayama K
Jpn J Clin Oncol; 2007 May; 37(5):365-9. PubMed ID: 17578895
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
14. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
[TBL] [Abstract][Full Text] [Related]
15. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.
Taguchi A; Ohmiya N; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
J Gastroenterol Hepatol; 2006 Mar; 21(3):545-51. PubMed ID: 16638096
[TBL] [Abstract][Full Text] [Related]
16. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
18. [Potentialities of a serological method in diagnosis of atrophic gastritis].
Pimenov SI; Makarenko EV
Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
20. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]